Actively Recruiting
Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome
Led by Tanta University · Updated on 2025-09-04
40
Participants Needed
1
Research Sites
16 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates suffering from respiratory distress syndrome.
CONDITIONS
Official Title
Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Prematurity
- Gestational age between 28 and 36 weeks
- Suffering from respiratory distress syndrome
You will not qualify if you...
- Intrauterine growth restriction (IUGR)
- Hypoxic ischemic encephalopathy
- Multiple congenital anomalies
- Chromosomal abnormalities
- Preterm less than 28 weeks
- Neonates with a maternal history of chorioamnionitis (early sepsis)
- Infant of diabetic mother
- Prelabor rupture of membranes (PROM) > 2 hours
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527
Actively Recruiting
Research Team
A
Asmaa M Elmesiry, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here